◀ Back to GHRH
CRH — GHRH
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Honegger et al., Endocrinology 1991
:
Stimulation of
GHRH and SRIH could not be
blocked by the CRH-antagonist alpha-helical
CRH ( 9-41 ) at 10 ( -6 ) M. Interleukin-6, in the dose range 10-100 U/ml, and tumor necrosis factor-alpha, in the dose range 10-10,000 U/ml, had no effect on the acute hypothalamic release of either GHRH or SRIH
Luque et al., Endocrinology 2007
:
These observations, in light of previous reports showing both NPY and
CRH can
inhibit GHRH expression and GH release, suggest that these neuronal systems may work in concert to control the ultimate impact of fasting on GH axis function
Nakane et al., Life Sci 1987
(Pituitary Neoplasms) :
Corticotropin releasing factor (CRF) and both human pancreatic growth hormone releasing factor ( hp-GRF ) and rat hypothalamic GRF ( rh-GRF ) stimulated ACTH release from neoplastic AtT-20 mouse pituitary tumor cells in a dose dependent fashion, with
CRF inducing a 10-fold increase and
GRF a maximal increment of approximately one-half that of CRF